Pharmaceuticals
Viking Therapeutics Shares Plunge After High Dropout Rate in Weight-Loss Pill Trial
Strong weight reduction overshadowed by concerns over side effects Viking Therapeutics (VKTX) shares plummeted nearly 45% on Tuesday after the...
Eli Lilly Strikes $1.3 Billion Deal with Superluminal Medicines to Advance AI-Driven Obesity Drug Development
Partnership leverages artificial intelligence to accelerate discovery of next-generation treatments for obesity and cardiometabolic diseases Eli Lilly (LLY) has entered...
Eli Lilly Posts Strong Q2 Earnings but GLP-1 Pill Disappointment Weighs on Stock
Zepbound and Mounjaro Drive U.S. Sales, Yet Orforglipron Trial Results Raise Investor Concerns Eli Lilly (LLY) delivered a solid second-quarter...
EXCLUSIVE: MIRA Pharmaceuticals’ Disruptive Path In Neurology And Metabolic Disorders
CEO Erez Aminov on Breakthrough Drug Candidates, Strategic Acquisitions, and the Vision Behind MIRA’s Innovation-Driven Pipeline MIRA Pharmaceuticals (NASDAQ: MIRA),...
MIRA Pharmaceuticals Secures Key Publication for Ketamir-2, a Next-Gen Ketamine Analog
Peer-reviewed journal spotlights differentiated pharmacology and therapeutic promise for neuropathic pain MIRA Pharmaceuticals (MIRA), a clinical-stage biotech firm focused on...
Telomir Pharmaceuticals Reports Breakthrough Anti-Aging Results in Preclinical Werner Syndrome Model
Lead candidate Telomir-1 reverses aging markers, restores muscle mass, and boosts survival in genetic progeria model Telomir Pharmaceuticals (TELO), a...
Telomir Pharmaceuticals Reports Breakthrough in Oral Therapy for Vision Loss
Telomir-1 reverses retinal degeneration and restores vision in advanced AMD zebrafish model Telomir Pharmaceuticals (TELO) announced a major preclinical breakthrough...
Telomir Pharmaceuticals Secures $3M Premium Equity Investment to Advance Rare Disease Program
Insider-Led Funding with No Warrants Strengthens Balance Sheet Ahead of IND Submission for Telomir-1 Telomir Pharmaceuticals (TELO), a biotech innovator...
Institutional Interest In Telomir Pharmaceuticals
Telomir Pharmaceuticals (TELO) has caught the attention of institutional investors, with JPMorgan Chase & Co. (JPM) significantly increasing its position...
Mira Pharmaceuticals Approves Acquisition of SKNY, Creating $60M+ Biotech Platform
Board approves merger following independent valuation; SKNY to contribute $5M in cash or assets at closing Mira Pharmaceuticals (MIRA), a...
